A measurable result is an actionable result. It gives you the assurance to determine the best course of treatment and the confidence to adapt your care. Results that can be used to better inform the decisions you make for each patient, or to inform the research that will develop more specific indications for imaging equipment and radiopharmaceuticals.
Our vision for molecular imaging is to provide you with the important instruments you need to see and the ability to prove what is seen, and often not seen. It's why we committed ourselves to bringing you quantitative applications with Xeleris 4.0.
Let Xeleris 4.0 guide your path to your next true discovery.
1In clinical practice, Evolution options1a (Evolution for Bone, Evolution for Cardiac, Evolution for Bone Planar) and Evolution Toolkit1b are recommended for use following consultation of a Nuclear Medicine physician, physicist and/or application specialist to determine the appropriate dose or scan time reduction to obtain diagnostic image quality for a particular clinical task, depending on the protocol adopted by the clinical site.
1aEvolution Options - Evolution claims are supported by simulation of count statistics using default factory protocols and imaging of 99mTc based radiotracers with LEHR collimator on anthropomorphic phantom or realistic NCAT – SIMSET phantom followed by quantitative and qualitative images comparison.
1bEvolution Toolkit - Evolution Toolkit claims are supported by simulation of full count statistics using lesion simulation phantom images based on various radiotracers and collimators and by showing that SPECT image quality reconstructed with Evolution Toolkit provide equivalent clinical information but have better signal-to-noise, contrast, and lesion resolution compared to the images reconstructed with FBP / OSEM.